Molecular Diagnostics

From genetic research to leading innovations in disease detection.

My career in molecular biology began with a focus on human genetics during my Master’s studies at Universidad de Antioquia, Colombia, where I honed my skills in analyzing DNA and RNA to identify genetic markers (SNPs, Indels, and DNA Microsatellites) linked to human diversity and disease susceptibility. Over the last 15 years, I transitioned from traditional genotyping methods such as RFLPs and capillary electrophoresis to advanced PCR and NGS techniques. This progression has significantly enhanced my ability to detect critical biomarkers across various species.

At EDAN Diagnostics, I lead efforts to develop innovative diagnostic assays, leveraging my expertise in molecular biology and population genetics to efficiently enhance the accuracy of infectious disease diagnostics. Additionally, through my venture, GenMol X, I aim to offer personalized genomic insights, pushing the boundaries of precision medicine with sophisticated AI-driven diagnostic solutions.

SOME OF MY ACCOMPLISSTMETS

Developed a molecular diagnostic assays for the EDAN's ClariLIght CL30 POC device, enabling the detection of SARS-CoV-2, Influenza A/B, RSV, Chlamydia trachomatis and Neisseria gonorrhoeae in human samples.

Genetic make up and structure of Colombian populations by means of uniparental and biparental DNA markers.

YOU CAN ALSO FIND ME ON

American Type Culture Collection (ATCC), EDAN Diagnostics, Inc., University of Wisconsin, Illumina, Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California, Inc. (PacBio), and Pharmaceutical Product Development, LLC (PPD), part of Thermo Fisher Scientific Inc., are all registered trademarks of their respective owners. The use of these names on this website is for informational and descriptive purposes only and does not imply any affiliation with or endorsement by them. Any copyrights referenced pertain to their respective owners.